Filing Details

Accession Number:
0001415889-24-025975
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-04 16:30:10
Reporting Period:
2024-11-01
Accepted Time:
2024-11-04 16:30:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1082554 United Therapeutics Corp UTHR Pharmaceutical Preparations (2834) 521984749
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1673232 Michael Benkowitz C/O United Therapeutics Corporation
1000 Spring Street
Silver Spring MD 20910
President And Coo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-01 14,700 $120.26 14,700 No 4 M Indirect By Trust
Common Stock Disposition 2024-11-01 200 $370.65 14,500 No 4 S Indirect By Trust
Common Stock Disposition 2024-11-01 800 $371.71 13,700 No 4 S Indirect By Trust
Common Stock Disposition 2024-11-01 1,200 $373.05 12,500 No 4 S Indirect By Trust
Common Stock Disposition 2024-11-01 6,096 $374.02 6,404 No 4 S Indirect By Trust
Common Stock Disposition 2024-11-01 3,501 $375.06 2,903 No 4 S Indirect By Trust
Common Stock Disposition 2024-11-01 1,803 $375.83 1,100 No 4 S Indirect By Trust
Common Stock Disposition 2024-11-01 1,000 $376.94 100 No 4 S Indirect By Trust
Common Stock Disposition 2024-11-01 100 $378.00 0 No 4 S Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options Disposition 2024-11-01 14,700 $0.00 14,700 $120.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,500 2017-03-15 2026-03-15 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,577 Direct
Footnotes
  1. Reflects the exercise of options held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.
  2. This transaction was executed in multiple trades at prices ranging from $370.38 to $370.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $371.41 to $372.2775. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $372.434 to $373.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $373.4616 to $374.4129. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $374.47 to $375.4685. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  7. This transaction was executed in multiple trades at prices ranging from $375.4825 to $376.3012. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  8. This transaction was executed in multiple trades at prices ranging from $376.5701 to $377.2793. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.